Profilo
Mingyue Cai is currently an Independent Director at Advanced Biomed, Inc. since 2025 and Vice President at Yitu Safety Technology Shenzhen Co. Ltd. Former positions include Administrative Director at Rugao Port Group Co. Ltd. from 2009 to 2017, Independent Director at GD Culture Group Ltd. from 2020 to 2024, and Manager at Shanghai Rishan Environmental Protection Technology Co. Ltd. from 2004 to 2009.
Education includes an undergraduate degree from Open University of China, conferred in 2015.
Posizioni attive di Mingyue Cai
| Società | Posizione | Inizio |
|---|---|---|
| ADVANCED BIOMED INC. | Direttore/Membro del Consiglio | 11/02/2025 |
Yitu Safety Technology Shenzhen Co. Ltd. | Corporate Officer/Principal | - |
Precedenti posizioni note di Mingyue Cai
| Società | Posizione | Fine |
|---|---|---|
| GD CULTURE GROUP LIMITED | Direttore/Membro del Consiglio | 26/04/2024 |
Rugao Port Group Co. Ltd.
Rugao Port Group Co. Ltd. Other TransportationTransportation Operates ports and harbors | Direttore Amministrativo | 01/08/2017 |
Shanghai Rishan Environmental Protection Technology Co. Ltd. | Corporate Officer/Principal | 01/10/2009 |
Formazione di Mingyue Cai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Open University of China
Open University of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rugao Port Group Co. Ltd.
Rugao Port Group Co. Ltd. Other TransportationTransportation Operates ports and harbors | Transportation |
GD Culture Group Ltd.
GD Culture Group Ltd. Packaged SoftwareTechnology Services Operates as a holding company which develops an IOT platform | Technology Services |
Yitu Safety Technology Shenzhen Co. Ltd. | |
Shanghai Rishan Environmental Protection Technology Co. Ltd. | |
Advanced Biomed, Inc.
Advanced Biomed, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development & production of microfluidic biochip technologies | Health Technology |
















